HomeCoronary diseaseDrug-eluting stents

Drug-eluting stents

Very Late Thrombosis in Bioresorbable Scaffolds

The presence of a metallic device interrupts normal laminar flow and creates an artery environment that favors...

Polymer-Free DES Also Show Efficacy in Anticoagulated Patients with High Risk for Bleeding

Patients who receive chronic anticoagulation therapy and then undergo angioplasty are frequently discharged on a triple anti-thrombotic...

Self-Expanding Stents Are Superior to Balloon-Expandable Stents in the Iliac Arteries

Courtesy of Dr. Carlos Fava. Severe atherosclerotic disease in iliac arteries is experienced by 15% of all men and 5%...

Should We Begin to Use IVUS in CTO?

Courtesy of Dr. Carlos Fava. Currently, chronic total occlusions (CTO) are one of the obstacles that coronary angioplasties must overcome, particularly with the...

Are Bioresorbable-Polymer Stents More Thrombogenic than Durable-Polymer Second-Generation Stents?

Courtesy of Dr. Cristian Jesús Rodríguez. Most stents currently used in percutaneous coronary intervention (PCI) are durable-polymer second-generation...

SOLACI 2017 | BRS: Present & Future

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Stephen...

SOLACI CACI 2017 | BRS: Presente y Futuro

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Stephen...

SOLACI CACI 2017 | BRS at the crossroad: technological development to reduce complications

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Patrick...